Recombinant IGF1R (Dalotuzumab Biosimilar) antibody

Catalog No. ABIN7581463

The Human Monoclonal anti-IGF1R (Dalotuzumab Biosimilar) antibody has been validated for ELISA, BLI, FACS, Func and SPR. It is suitable to detect IGF1R (Dalotuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IGF1R (Dalotuzumab Biosimilar) antibody (ABIN7581463)

Target: IGF1R (Dalotuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IGF1R (Dalotuzumab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-IGF1R (Dalotuzumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-IGF1R / CD221 Reference Antibody (dalotuzumab)

Characteristics: Anti-IGF1R / CD221 Reference Antibody (dalotuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for IGF1R (Dalotuzumab Biosimilar)

Target: IGF1R (Dalotuzumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P08069